TipRanks
ACADIA Pharmaceuticals (DE:DR6)
FRANKFURT:DR6
Germany Market
DR6
ACADIA Pharmaceuticals
RESEARCH TOOLSreports

ACADIA Pharmaceuticals (DR6) Stock News & Sentiment

0 Followers
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
Premium
Company Announcements
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
10d ago
8K
ACAD
Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
Premium
Company Announcements
Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
22d ago
8K
ACAD
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
Premium
Ratings
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
1M ago
ACAD
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
Premium
Ratings
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
1M ago
ACAD
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
Premium
Ratings
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
1M ago
ACAD
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
Premium
Market News
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
2M ago
JNJ
MRK
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
Premium
Ratings
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
2M ago
ACAD
More DE:DR6 News >

DR6 News on the Web

BAKER BROS. ADVISORS LP Expands Stake in Kodiak Sciences Inc (KOD) with 2.13 Million Share Purchase
GuruFocus News
Neutral
BMO Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Kyverna Therapeutics, Inc. (KYTX)
TipRanks News
Bullish
Acadia Pharmaceuticals price target lowered to $34 from $36 at BMO Capital
TipRanks News
Neutral
ACADIA Pharmaceuticals (ACAD) Gets ‘Sell’ Rating on Weak Trial Results, Shares Fall 13%
Insider Monkey
Bearish
Acadia Reports Phase 2 Data for Alzheimer’s Psychosis
TipRanks News
Bullish
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
TipRanks News
Bullish
Neurocrine's Ingrezza Sales Keep Growing: Can the Momentum Last?
Zacks
Neutral

News Score - Last 7 Days

Neutral
DE:DR6
Sector Average
Media Buzz
This Week4 articles
Weekly Average6.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:DR6’s Media Buzz Sentiment?
4 articles about DE:DR6 were published this week. In an average week, 6.5 articles are published.
    What is DE:DR6’s weekly average amount of articles?
    In an average week, 6.5 articles about DE:DR6 are published.
      What is DE:DR6’s News Sentiment?
      50% of articles about DE:DR6 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        RHHBYRoche Holding
        BAYRYBayer
        SNYSanofi
        CICigna
        TFXTeleflex
        Showing the stocks with the most bullish news sentiment over the past week